Upload

Loading icon Loading...

This video is unavailable.

Ajay Kirtane, MD, SM Discusses FAME 2 Trial Results with SCAI President

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add SCAITV's video to your playlist.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like SCAITV's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike SCAITV's video.

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Published on Sep 5, 2012

Ajay Kirtane, MD, SM, FSCAI, and SCAI President J. Jeffrey Marshall, MD, FSCAI discuss the FAME 2 trial, in which FFR was performed on every patient to confirm that "hemodynamically significant" (or "tight") blockages in their coronary arteries were limiting blood flow. The patients with hemodynamically significant blockages were then randomized to PCI plus the best medications available or medications alone.

Read the SCAI statement on FAME 2 at http://www.scai.org/Press/detail.aspx...

  • Category

  • License

    Standard YouTube License

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to